DART MEDICAL LABORATORY INC NPI 1821110453

NPI Information

  • NPI: 1821110453
  • Provider Name: DART MEDICAL LABORATORY, INC
  • Classification: Clinical Medical Laboratory - 291U00000X
  • Entity Type: Organization
  • Address: 140 58TH ST, BUILDING A
    UNIT 3L
    BROOKLYN, NY
    ZIP 11220
  • Phone: (718) 934-1918

Map and Directions

Get Directions

NPI Details

DART MEDICAL LABORATORY, INC is a clinical medical laboratory in Brooklyn, NY. The provider is (1) A clinical laboratory is a facility for the biological, microbiological, serological, chemical, immunohematological, hematological, biophysical, cytological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, human beings. These examinations also include procedures to determine, measure, or otherwise describe the presence or absence of various substances or organisms in the body. Facilities only collecting or preparing specimens (or both) or only serving as a mailing service and not performing testing are not considered clinical laboratories. (2) Any facility that examines materials from the human body for purposes of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of, the health of human beings. Typical divisions of a clinical laboratory include hematology, cytology, bacteriology, histology, biochemistry, medical toxicology, and serology. DART MEDICAL LABORATORY, INC NPI is 1821110453. The provider is registered as an organization entity type.

The provider's business location address is:

140 58TH ST, BUILDING A
UNIT 3L
BROOKLYN, NY
ZIP 11220
Phone: (718) 934-1918
Fax: (718) 934-2003

The provider's authorized official is Galina Golub .
The authorized official title is Manager and has the following contact phone number (917) 538-8418.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
  • Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
  • Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source (HCPCS:G2023)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge (HCPCS:P9604)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19), influenza virus types a and b, and respiratory syncytial virus (HCPCS:87637)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19) and influenza virus types a and b (HCPCS:87636)
  • Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
  • Hemoglobin a1c level (HCPCS:83036)
  • Natriuretic peptide (heart and blood vessel protein) level (HCPCS:83880)
  • Automated urinalysis test (HCPCS:81003)
  • Measure of severe acute respiratory syndrome coronavirus 2 (covid-19) antibody (HCPCS:86769)
  • Magnesium level (HCPCS:83735)
  • Bacterial colony count, urine (HCPCS:87086)
  • Nucleotidase 5' (enzyme) level (HCPCS:83915)
  • Phosphate level (HCPCS:84100)
  • Blood test, clotting time (HCPCS:85610)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • Folic acid level, serum (HCPCS:82746)
  • Vitamin d-3 level (HCPCS:82306)
  • Iron level (HCPCS:83540)
  • Red blood cell sedimentation rate, to detect inflammation, non-automated (HCPCS:85651)
  • Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
  • Thyroid hormone evaluation (HCPCS:84479)
  • Transferrin (iron binding protein) level (HCPCS:84466)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Valproic acid level, total (HCPCS:80164)
  • Parathormone (parathyroid hormone) level (HCPCS:83970)
  • Coagulation assessment blood test, plasma or whole blood (HCPCS:85730)
  • Bacterial urine culture (HCPCS:87088)
  • Thyroxine (thyroid chemical), total (HCPCS:84436)
  • Uric acid level, blood (HCPCS:84550)
  • Red blood count, manual test (HCPCS:85044)
  • Vancomycin (antibiotic) level (HCPCS:80202)
  • Special gram or giemsa stain for microorganism (HCPCS:87205)
  • Bacterial blood culture (HCPCS:87040)
  • Stool analysis for blood, by peroxidase activity (HCPCS:82272)
  • Thyroxine (thyroid chemical), free (HCPCS:84439)
  • Coagulation function measurement, d-dimer; quantitative (HCPCS:85379)
  • Creatine kinase (cardiac enzyme) level, total (HCPCS:82550)
  • Psa (prostate specific antigen) measurement, total (HCPCS:84153)
  • Digoxin level, total (HCPCS:80162)
  • Iron binding capacity (HCPCS:83550)
  • Bacterial culture, any other source except urine, blood or stool, aerobic (HCPCS:87070)
  • Bacterial culture, any source, except blood, anaerobic (HCPCS:87075)
  • Detection test by immunoassay technique for clostridium difficile toxins (stool pathogen) (HCPCS:87324)
  • Detection test by nucleic acid for multiple types of respiratory virus, multiple types or subtypes, 3-5 targets (HCPCS:87631)
  • Liver function blood test panel (HCPCS:80076)
  • Prealbumin (protein) level (HCPCS:84134)
  • Troponin (protein) analysis, quantitative (HCPCS:84484)
  • Bacterial culture for anaerobic isolates (HCPCS:87076)
  • Thyroid hormone, t3 measurement, total (HCPCS:84480)
  • Thyroid hormone, t3 measurement, free (HCPCS:84481)
  • Urine microalbumin (protein) level (HCPCS:82043)
  • Stool culture (HCPCS:87045)
  • Detection test by nucleic acid for organism, amplified probe technique (HCPCS:87798)
  • Detection test by nucleic acid for chlamydia pneumoniae, amplified probe technique (HCPCS:87486)
  • Detection test by nucleic acid for mycoplasma pneumoniae (bacteria), amplified probe technique (HCPCS:87581)

The enumeration date for this NPI number is 4/4/2007 and was last updated on 10/25/2021.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1291U00000XClinical Medical Laboratory33D1020120NEW YORKYes

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 3/30/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.